Gillian Cannon - 10 Sep 2025 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Reporting relationship: Director
Issuer ticker: CORT
Reported as of: 10 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Sep 2025, 21:03:44 UTC
Prior SEC filing: 08 Sep 2025
Next SEC filing: 03 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for Gillian M. Cannon.

Key filing fact

Gillian Cannon filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 11 Sep 2025.

Key facts

This page summarizes Gillian Cannon's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Sep 2025, 21:03.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001833910 Primary reporting owner

Relationship: Director
Address: C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Signature: /s/ Joseph Douglas Lyon, as attorney-in-fact for Gillian M. Cannon.
Signature date: 11 Sep 2025

Shares, units, or other non-derivative securities reported in this filing.

CORT transaction

Gift

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Represents a donation by the Reporting Person to Fidelity Charitable Giving Account.

SEC remarks

The power of attorney under which this form was signed is on file with the Commission.